When we talk to customers about what an agent should be allowed to do in their workspace, the most common

Somewhere in the world right now, a scientist is taking a photograph of a paper lab notebook, uploading the image

Biotech outcomes are binary and milestone-gated, and the math on that doesn't really have a gradient: if

When we started building Kaleidoscope, we didn’t set out to build an end-to-end platform. Our initial observation

In the last few weeks, three separate prospects reached out to us in what looked like sudden bursts of interest.

A question we hear often from biopharma leadership and investors: "With AI improving this fast, do we really need

There's a harmful posture across biopharma that is hampering meaningful progress: a belief that certain categories of work

Most onboarding journeys hit an early inflection point: a moment when it becomes clear whether the software will actually stick.

When your timelines are measured in years rather than weeks - as they are in the biopharma world - partnership and support

The right technical people can be a huge competitive advantage in industries like biopharma. The challenge becomes attracting and retaining